Advancements in medical technology and research highlight shifts in clinical care, surgical regulation, and disease treatment.

Surgical royal colleges have issued a warning regarding a regulatory gap in cosmetic surgery, noting that government delays leave patients vulnerable to under-qualified practitioners.

New data indicates a sharp decline in bariatric surgery volumes since 2022, though surgical quality remains high despite an increase in the complexity of patients being treated.

A Dutch study reports a rising incidence of pediatric-onset multiple sclerosis, with findings suggesting that viral exposure during the COVID-19 pandemic may influence disease development.

The FDA has approved Oveporexton, the first drug designed to treat the biological root of narcolepsy type 1 by directly restoring orexin signaling.

Researchers have developed an AI deep learning framework that accurately classifies nine renal tumor subtypes and outperforms traditional methods in predicting patient outcomes.

A longitudinal study confirms that while obesity and heavy alcohol intake significantly boost diabetes risk, low-to-moderate alcohol consumption has a negligible impact on individuals without obesity.

Nutrition experts warn that prebiotic sodas are often marketed with misleading health claims and may not provide the significant gut health benefits promised to consumers.

Medical experts are advocating for a transition to integrated, multimodal care models to address the limitations of fragmented treatments for patients suffering from chronic back pain.